Early prediction of lung injury in very preterm infants using EIT and lung ultrasound
Official title: Electrical Impedance Tomography and Lung Ultrasound Score in Early Prediction of Bronchopulmonary Dysplasia in Preterm and Very Low Birth Weight Infants.
Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07265583 · Data updated 2026-11-12
This project will test whether bedside Electrical Impedance Tomography (EIT) and lung ultrasound in stable preterm babies on non-invasive breathing support can spot uneven lung ventilation that predicts severe BPD or death by 36 weeks postmenstrual age.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 26 Weeks to 32 Weeks |
| Sex | All |
| Enrollment | 104 (estimated) |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 1 site (Pavia) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | July 1, 2026 |
| Study ends | July 1, 2027 |
| Registry record updated | December 5, 2025 |
| Trial ID | NCT07265583 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are inborn very preterm infants (26–32 weeks' gestation and/or birthweight <1500 g) with respiratory distress syndrome who are on nCPAP or HFNC at 72 hours of life and whose parents provide consent.
✕Probably not a fit
Infants who are outborn, intubated and mechanically ventilated for more than 72 hours, have major congenital or genetic anomalies, skin conditions preventing EIT, or other life‑threatening comorbidities are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will enroll 104 very preterm infants (26–32 weeks' gestation and/or birthweight <1500 g) with respiratory distress syndrome who remain on non-invasive ventilation (nCPAP or HFNC) at 72 hours of life at the NICU in Pavia, Italy. Investigators will perform bedside Electrical Impedance Tomography (EIT) during the first weeks of life to quantify ventilation homogeneity and will collect standard lung ultrasound (LUS) scores. EIT-derived homogeneity parameters and LUS scores will be compared with clinical outcomes, specifically bronchopulmonary dysplasia grade 3 at 36 weeks postmenstrual age or death, to see if early ventilation inhomogeneity predicts later severe lung injury. All measurements are observational, will not alter routine care, and enrollment will be consecutive with informed parental consent.
Why it matters
Potential benefit: If successful, early detection of uneven ventilation could let clinicians tailor non-invasive support sooner and may reduce the risk of severe BPD.
How similar studies have gone: Prior neonatal work has used EIT and lung ultrasound to monitor regional aeration and ventilation, but using early EIT homogeneity measures specifically to predict severe BPD is relatively novel and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: preterm infants born between 26 and 32 weeks of gestational age and/or with a birth weight \< 1500g (very low birth weight infants - VLBW) with respiratory distress syndrome (RDS). \- Exclusion Criteria: - outborn infants * complex congenital malformations * metabolic, chromosomal, or other genetic abnormalities * pulmonary hypoplasia, congenital anomalies of surfactant proteins or other pulmonary abnormalities * any skin anomalies * need for mechanical ventilation \> 72h after birth * any life-threatening comorbidity or any other medical condition which, in the opinion of the investigator, makes the patient unsuitable for inclusion. * lack of parent consent.
Where it's running
-
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy Recruiting
Study contacts
- Principal investigator: Stefano Ghirardello, MD — NICU, Fondazione IRCCS Policlinico San Matteo
- Study coordinator: Stefano Ghirardello, MD
- Email: s.ghirardello@smatteo.pv.it
- Phone: +3903825025218
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Cervical stiffness test to help predict preterm birth in at-risk pregnant women
A simple cervical stiffness test using the Pregnolia device is being studied to see if it can better identify women with threatened preterm labor who are likely to give birth soon.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
How doctors and nurses decide about bed rest in pregnancy
This study tests a plan to stop routinely restricting activity or bed rest during pregnancy to see if providers accept it, find it appropriate, and change how often they recommend it for women at risk of preterm birth.
-
How cervical ultrasound settings affect AI prediction of preterm birth
This study tests whether an AI model for predicting preterm birth performs differently when cervical ultrasound images are taken with different imaging settings.
-
Surfactant delivery methods in preterm infants with RDS in Sweden
This study tests different ways of giving surfactant to preterm babies with respiratory distress to see which method works best when care is routine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.